Article

A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense Therapy

2020-09-14

Abstract excerpt

As of July 25-2020, 643,412 people in more than 215 countries have been victims of the new type of coronavirus, SARS-CoV-2. Thereby, there is a huge effort to develop a strategy to treat, and or prevent people from SARS-CoV-2 infection. Those efforts could be mainly categorized as drug repurposing, anti-SARS-CoV-2 antibodies from people who recovered, and vaccines. However, there is currently no specific trea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 536472f3-44e3-500f-bc4d-703878eb73b4
DOI: 10.26434/chemrxiv.12948746.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Promising Strategy Against SARS-CoV-2 Infected Patients: Antisense TherapyDOI 10.26434/chemrxiv.12948746.v1Read

<strong>Think Different with RNA Therapy: Can Antisense Oligonucleotides Be Used to Inhibit Replication and Transcription of SARS-Cov-2?</strong>Semantic proximity Read

Antisense oligonucleotides to therapeutically target SARS-CoV-2 infectionSemantic proximity Read

Antisense oligonucleotide: A promising therapeutic option to beat COVID ‐19Semantic proximity Read

Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeuticsSemantic proximity Read

Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 InfectionSemantic proximity Read

Inhibition of SARS-CoV-2 by Targeting Conserved Viral RNA Structures and SequencesSemantic proximity Read

RNA interference as a promising treatment against SARS-CoV-2Semantic proximity Read

Development and application of ribonucleic acid therapy strategies against COVID-19Semantic proximity Read

Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral InhibitorsSemantic proximity Read

SARS-CoV-2 RNA polymerase as target for antiviral therapySemantic proximity Read

Aptamer‐based strategies against SARS‐CoV‐2 virusesSemantic proximity Read

Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.Semantic proximity Read